Calibr at Scripps Research
Chan Beals has an extensive work experience in the field of pharmaceutical and biotech companies. Chan is currently serving as the Chief Medical Officer at Calibr at Scripps Research since January 2023. Prior to this, they held the position of SVP Translational Medicine at Autobahn Therapeutics, Inc. starting from January 2020.
From 2016 to 2020, Chan Beals worked as the Chief Medical Officer at Abide Therapeutics. Before that, they were the Vice President of Clinical Pharmacology at Merck from an unspecified date in 2012 to December 2015.
Chan Beals also has previous experience at Merck as the Senior Director and Head of Experimental Medicine from an unknown start date in 2006 to 2011. Before joining Merck, they held the position of Director at Pfizer from an unspecified date in 2002 to 2006. And prior to that, they worked as a Sr Scientist at ICOS Corporation from an unknown start date in 1997 to 2002.
Chan Beals studied at the Massachusetts Institute of Technology from 1979 to 1983, where they obtained a Bachelor of Science degree in Chemistry. Following that, Beals attended the University of Washington - School of Medicine from 1983 to 1990, where they earned a Doctor of Medicine (M.D.) degree with a focus on Biochemistry. Beals then pursued further education at the University of California, San Francisco from 1990 to 1997, specializing in Pediatrics and Pediatric Rheumatology but without obtaining a specific degree.